Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,” the firm’s Nobel Prize-winning CEO Demis Hassabis told a panel at the World Economic Forum in Davos this week. “That’s the plan.” The potential of AI-powered drug discovery is huge. Instead of spending years or even decades testing chemicals by hand, machine learning algorithms can sift through mountains of data to spot patterns and predict which molecules could…This story continues at The Next Web [...]
At start of December, Google DeepMind released Genie 2. The Genie family of AI systems are what are known as world models. They're capable of generating images as the user — either a human or, [...]
Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]
Fetch AI, a startup founded and led by former DeepMind founding investor, Humayun Sheikh, today announced the release of three interconnected products designed to provide the trust, coordination, and [...]
Here's an AI-government collaboration of a less… unsettling variety than some. Google DeepMind is teaming up with the National Hurricane Center (NHC) for tropical cyclone season. The AI researc [...]
Paramount Skydance CEO David Ellison is apparently still hopeful that investors will approve his $108.4 billion hostile takeover of Warner Bros. Discovery. Paramount Skydance announced Thursday that i [...]
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligen [...]